NUS (NuSkin Enterprises, Inc.) Stock Analysis - Analyst Ratings

NuSkin Enterprises, Inc. (NUS) is a publicly traded Consumer Defensive sector company. As of May 21, 2026, NUS trades at $5.84 with a market cap of $284.51M and a P/E ratio of 5.18. NUS moved +2.46% today. Year to date, NUS is -39.73%; over the trailing twelve months it is -23.06%. Its 52-week range spans $5.32 to $14.62. Rallies surfaces NUS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What do analysts rate NUS?

The average price target is $0.00.

NUS Key Metrics

Key financial metrics for NUS
MetricValue
Price$5.84
Market Cap$284.51M
P/E Ratio5.18
EPS$1.13
Dividend Yield0.06%
52-Week High$14.62
52-Week Low$5.32
Volume537.37K
Avg Volume0
Revenue (TTM)$1.44B
Net Income$54.52M
Gross Margin69.31%

NUS Analyst Consensus

NUS analyst coverage data. Average price target: $0.00.

Latest NUS News

Recent NUS Insider Trades

  • Nathanson Laura sold 2.68K (~$18.01K) on May 11, 2026.
  • Hatchett Steven Keith bought 5.50K (~$52.85K) on Nov 11, 2025.
  • Nathanson Laura sold 6.49K (~$79.30K) on Sep 4, 2025.

Common questions about NUS

What do analysts rate NUS?
The average price target is $0.00.
Does Rallies show NUS price targets?
Yes. Rallies tracks NUS analyst ratings, consensus rating, average price target, upgrades, downgrades, analyst firms, and recent price target changes when available.
Is NUS research on Rallies investment advice?
No. Rallies provides research, data, and educational context for NUS. It does not provide personalized investment advice.
NUS

NUS